STOCK TITAN

NeuroPace: Front Foot Trust buys 12,500 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Front Foot Trust purchased 12,500 NeuroPace shares on November 18, 2026, at a weighted average price of $8.2929 per share; individual purchases ranged from $8.2350 to $8.3657. Director R. Scott Huennekens and a member of his immediate family serve as trustees. Huennekens disclaims beneficial ownership except to the extent of his pecuniary interest. The purchases complied with Rule 10b-18 restrictions and broker-dealer and issuer pre-clearance procedures. The purchase was not reported as made pursuant to a Rule 10b5-1 plan.

Insider Huennekens R Scott
Role Director
Bought 12,500 shs ($104K)
Type Security Shares Price Value
Purchase Common Stock F2, F1, F3 12,500 $8.2929 $104K
Holdings After Transaction: Common Stock — 12,500 shares (Indirect, By Front Foot Trust)
Footnotes (3)
  1. F1. Purchases made in compliance with SEC Rule 10b-18 safe harbor restrictions for manner, timing, price, and volume of purchase. Purchases also complied with broker-dealer and issuer pre-clearance procedures.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.2350 to $8.3657, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.
  3. F3. Shares owned by the Front Foot Trust. Mr. Huennekens and a member of his immediate family serve as trustees of the trust. The reporting person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
Shares purchased 12,500 shares Front Foot Trust purchase on November 18, 2026
Weighted average purchase price $8.2929 per share Front Foot Trust purchase on November 18, 2026
Purchase price range $8.2350–$8.3657 per share Multiple transactions on November 18, 2026
Shares following transaction 12,500 shares Shares owned by Front Foot Trust following the purchase
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Rule 10b-18 safe harbor restrictions regulatory
"Purchases made in compliance with SEC Rule 10b-18 safe harbor restrictions"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NPCE shares did Front Foot Trust purchase, and at what price?

Front Foot Trust purchased 12,500 shares at a weighted average of $8.2929 per share on November 18, 2026. The shares were purchased in multiple transactions ranging from $8.2350 to $8.3657.

Who held the shares associated with the NPCE purchase?

The shares were owned by Front Foot Trust. Director R. Scott Huennekens and a member of his immediate family serve as trustees. Huennekens disclaims beneficial ownership except to the extent of his pecuniary interest. The purchases complied with Rule 10b-18 restrictions and broker-dealer and issuer pre-clearance procedures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Huennekens R Scott

(Last)(First)(Middle)
C/O NEUROPACE, INC.
455 N. BERNARDO AVENUE

(Street)
MOUNTAIN VIEW CALIFORNIA 94043

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NeuroPace Inc [ NPCE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/18/2026PV12,500A(1)$8.2929(2)12,500(3)IBy Front Foot Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Purchases made in compliance with SEC Rule 10b-18 safe harbor restrictions for manner, timing, price, and volume of purchase. Purchases also complied with broker-dealer and issuer pre-clearance procedures.
2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.2350 to $8.3657, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.
3. Shares owned by the Front Foot Trust. Mr. Huennekens and a member of his immediate family serve as trustees of the trust. The reporting person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
Remarks:
/s/ Leah Akin, Attorney-in-Fact11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading